Most cited papers from Cancer Care Services

Cancer Care Services

What are the most cited papers from Cancer Care Services?

The most cited paper from Cancer Care Services is "A Systematic Review of Financial Toxicity Among Cancer Survivors: We Can’t Pay the Co-Pay" (Louisa G. Gordon, Katharina M. D. Merollini, Anthony Lowe et al., 2016), with 486 citations. Next come "Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma" (334) and "A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer" (251).

Published TypeFieldAccessCitations

Showing 50 of 60 papers. Every paper with more than 28 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	A Systematic Review of Financial Toxicity Among Cancer Survivors: We Can’t Pay the Co-Pay Louisa G. Gordon, Katharina M. D. Merollini, Anthony Lowe et al. · Patient ReviewOpen access	31 Oct 2016	486
2	Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma Neil D. Gross et al. · New England Journal of Medicine Open access	12 Sep 2022	334
3	A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer Martin Jean Schlumberger, Barbara Jarząb, Maria E. Cabanillas et al. · Clinical Cancer Research Open access	26 Aug 2015	251
4	Prevention and treatment of acute radiation-induced skin reactions: a systematic review and meta-analysis of randomized controlled trials Raymond J. Chan, Joan Webster, Bryan T. Chung et al. · BMC Cancer ReviewOpen access	31 Jan 2014	248
5	Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial Brett G.M. Hughes, E. Munoz-Couselo, Laurent Mortier et al. · Annals of Oncology Open access	20 Jul 2021	208
6	Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A Johnny Ndoni Mahlangu et al. · New England Journal of Medicine Open access	22 Feb 2023	201
7	Mapping unmet supportive care needs, quality-of-life perceptions and current symptoms in cancer survivors across the Asia-Pacific region: results from the International STEP Study Alex Molassiotis et al. · Annals of Oncology Open access	12 Jul 2017	164
8	Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial Jonathan A. Ledermann et al. · The Lancet Oncology Open access	30 Apr 2020	132
9	Radiological properties of 3D printed materials in kilovoltage and megavoltage photon beams Orrie Dancewicz, Steven R. Sylvander, Tim Markwell et al. · Physica Medica	29 May 2017	125
10	Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic Melanoma Ailin Lepletier et al. · Clinical Cancer Research Open access	28 Apr 2020	114
11	Radiotherapy for perineural invasion in cutaneous head and neck carcinomas: Toward a risk‐adapted treatment approach James E. Jackson, Graeme J. Dickie, Kirsty L. Wiltshire et al. · Head & Neck	8 Jan 2009	107
12	Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and Metastasis Arabella Young, Shin Foong Ngiow, Jason Madore et al. · Cancer Research	26 Jun 2017	102
13	Capture of Circulating Tumour Cell Clusters Using Straight Microfluidic Chips Arutha Kulasinghe, Jian Hong Zhou, Liz Kenny et al. · Cancers Open access	14 Jan 2019	86
14	Pitfalls of using estimations of glomerular filtration rate in an intensive care population Jennifer Martin, M. F. Fay, Andrew Alexander Udy et al. · Internal Medicine Journal	Jul 2011	82
15	A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy John A. Glaspy, J. Jadeja, Glen R. Justice et al. · British Journal of Cancer Open access	2001	81
16	Imetelstat-mediated alterations in fatty acid metabolism to induce ferroptosis as a therapeutic strategy for acute myeloid leukemia Claudia Bruedigam et al. · Nature Cancer Open access	30 Oct 2023	79
17	Randomised controlled trial of early prophylactic feeding vs standard care in patients with head and neck cancer Teresa Ellen Brown, Merrilyn Banks, Brett G.M. Hughes et al. · British Journal of Cancer Open access	23 May 2017	78
18	Phase I Biodistribution and Pharmacokinetic Study of Lewis Y–Targeting Immunoconjugate CMD-193 in Patients with Advanced Epithelial Cancers Rebecca A. Herbertson, Niall Christopher Tebbutt, Fook-Thean Lee et al. · Clinical Cancer Research Open access	14 Oct 2009	74
19	Effect of infusion set replacement intervals on catheter-related bloodstream infections (RSVP): a randomised, controlled, equivalence (central venous access device)–non-inferiority (peripheral arterial catheter) trial Claire M. Rickard et al. · The Lancet Open access	Apr 2021	71
20	A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6 Brett G.M. Hughes et al. · Journal of the American Academy of Dermatology	7 Sep 2024	68
21	A single-blind, randomised controlled trial of StrataXRT® – A silicone-based film-forming gel dressing for prophylaxis and management of radiation dermatitis in patients with head and neck cancer Raymond J. Chan, Rae Blades, Lee Jones et al. · Radiotherapy and Oncology Open access	21 Aug 2019	68
22	Three-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A Bella Madan et al. · Journal of Thrombosis and Haemostasis Open access	11 Apr 2024	66
23	A feasibility study for using ABS plastic and a low-cost 3D printer for patient-specific brachytherapy mould design Benjamin Harris, Sanna Nilsson, Christopher M. Poole · Australasian Physical & Engineering Sciences in Medicine	24 Jun 2015	62
24	Combination of Tolfenamic acid and curcumin induces colon cancer cell growth inhibition through modulating specific transcription factors and reactive oxygen species Umesh T. Sankpal, Ganji Purnachandra Nagaraju, Sriharika R. Gottipolu et al. · Oncotarget Open access	10 Dec 2015	61
25	Salivary High-Risk Human Papillomavirus (HPV) DNA as a Biomarker for HPV-Driven Head and Neck Cancers Chameera Ekanayake Weeramange, Zhen Yu Liu, Günter Härtel et al. · Journal of Molecular Diagnostics Open access	27 Jul 2021	58
26	Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian carcinoma David M. O’Malley et al. · Gynecologic Oncology Open access	20 Oct 2022	57
27	Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial Andrew P. Barbour et al. · Annals of Oncology Open access	6 Jan 2020	57
28	Unlocking the Potential of Saliva-Based Test to Detect HPV-16-Driven Oropharyngeal Cancer Kai Dun Tang, Kurt Baeten, Liz Kenny et al. · Cancers Open access	3 Apr 2019	57
29	Distinct effects of ruxolitinib and interferon-alpha on murine JAK2V617F myeloproliferative neoplasm hematopoietic stem cell populations Rebecca J. Austin et al. · Leukemia Open access	15 Nov 2019	56
30	An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervix Andrzej Piotr Kudelka, Rodger J. Winn, Creighton L. Edwards et al. · Anti-Cancer Drugs	Aug 1997	54
31	MPN: The Molecular Drivers of Disease Initiation, Progression and Transformation and their Effect on Treatment Julian Grabek, Jasmin Straube, Megan J. Bywater et al. · Cells Open access	14 Aug 2020	51
32	Increasing feasibility and utility of 18 F-FDOPA PET for the management of glioma Christopher James Bell, Nicholas Dowson, Simon G. Puttick et al. · Nuclear Medicine and Biology	13 Jun 2015	50
33	PET, MRI, and simultaneous PET/MRI in the development of diagnostic and therapeutic strategies for glioma Simon G. Puttick, Christopher James Bell, Nicholas Dowson et al. · Drug Discovery Today	6 Nov 2014	48
34	Efficacy, safety, and quality of life 4 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A in the phase 3 GENEr8-1 trial Andrew D. Leavitt et al. · Research and Practice in Thrombosis and Haemostasis Open access	31 Oct 2024	46
35	Oral HPV16 DNA as a screening tool to detect early oropharyngeal squamous cell carcinoma Kai Dun Tang, Sarju S. Vasani, Lilian Menezes et al. · Cancer Science Open access	26 Jul 2020	45
36	Quasi-simultaneous 3D printing of muscle-, lung- and bone-equivalent media: a proof-of-concept study Tanya Kairn, M. Zahrani, Naasiha Cassim et al. · Physical and Engineering Sciences in Medicine Open access	20 Apr 2020	45
37	Gemcitabine-based therapy in pancreas cancer Andrew D. Jacobs · Cancer Open access	19 Jul 2002	45
38	Noncoding RNAs in oral cancer Jaikrishna Balakittnen, Chameera Ekanayake Weeramange, Daniel F. Wallace et al. · Wiley Interdisciplinary Reviews - RNA ReviewOpen access	12 Aug 2022	43
39	Clinical guidance for radioiodine refractory differentiated thyroid cancer Matti L. Gild, Duncan J. Topliss, Diana Learoyd et al. · Clinical Endocrinology Open access	2 Nov 2017	41
40	DNA Methylation Changes in Human Papillomavirus-Driven Head and Neck Cancers Chameera Ekanayake Weeramange, Kai Dun Tang, Sarju S. Vasani et al. · Cells Open access	31 May 2020	40
41	Experiences and needs of people with haematological cancers during the COVID‐19 pandemic: A qualitative study Nienke Zomerdijk, Michelle I. Jongenelis, Eva Y. N. Yuen et al. · Psycho-Oncology Open access	9 Sep 2021	38
42	Oncology practitioners’ perspectives and practice patterns of post-treatment cancer survivorship care in the Asia-Pacific region: results from the STEP study on behalf of the STEP study collaborators, Raymond J. Chan, Patsy M. Yates et al. · BMC Cancer Open access	6 Nov 2017	38
43	A prospective comparison of times to presentation and treatment of regional and remote head and neck patients in North Queensland, Australia Joanne Yue-Ai Tan, Zulfiquer Ali Otty, Venkat Vangaveti et al. · Internal Medicine Journal Open access	Jun 2016	38
44	Models of survivorship care provision in adult patients with haematological cancer: an integrative literature review Karen Taylor, Raymond J. Chan, Leanne Monterosso · Supportive Care in Cancer	18 Feb 2015	38
45	Australian & New Zealand Faculty of Radiation Oncology Genito‐Urinary Group: 2010 consensus guidelines for definitive external beam radiotherapy for prostate carcinoma AJ Hayden, Jarad M. Martin, Andrew B. Kneebone et al. · Journal of Medical Imaging and Radiation Oncology	Dec 2010	38
46	A pilot study: Metabolic profiling of plasma and saliva samples from newly diagnosed glioblastoma patients Juliana Müller Bark, Avinash V. Karpe, James D. Doecke et al. · Cancer Medicine Open access	9 Apr 2023	37
47	Utilising the Virtual Environment for Radiotherapy Training System to Support Undergraduate Teaching of IMRT, VMAT, DCAT Treatment Planning, and QA Concepts Crispen Chamunyonga, Julie Burbery, Peter J. Caldwell et al. · Journal of medical imaging and radiation sciences	3 Jan 2018	37
48	Current evidence of education and safety requirements for the nursing administration of chemotherapy: An integrative review Elisabeth Coyne, Sarah Northfield, Kylie Ash et al. · European Journal of Oncology Nursing Open access	9 May 2019	36
49	Proteome profiling of salivary small extracellular vesicles in glioblastoma patients Juliana Müller Bark, Lucas Trevisan França de Lima, Xi Zhang et al. · Cancer Open access	31 May 2023	35
50	Tube feeding during treatment for head and neck cancer – Adherence and patient reported barriers Teresa Ellen Brown, Merrilyn Banks, Brett G.M. Hughes et al. · Oral Oncology	25 Jul 2017	34

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.